HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
ZSY 27
structure given in first source
Also Known As:
5-methyl-6-(4-pyridinyl)-2H-1,4-thiazine-3(4H)one HCl; ZSY-27; 2H-1,4-Thiazin-3(4H)-one, 5-methyl-6-(4-pyridinyl)-, monohydrochloride
Networked:
2
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Sulfur Compounds: 278
Thiazines: 3
ZSY 27: 2
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Thiazines: 3
ZSY 27: 2
Related Diseases
1.
Pulmonary Hypertension
02/01/1989 - "
This study suggests that ZSY-27 is a possible therapeutic agent for pulmonary hypertension secondary to PE.
"
02/01/1989 - "
Selective pulmonary vasodilatory effect of ZSY-27 in dogs with pulmonary hypertension due to pulmonary embolism.
"
02/01/1989 - "
The pulmonary vasodilator effect of ZSY-27, a newly synthesized phosphodiesterase inhibitor, was studied in dogs with pulmonary hypertension resulting from autologous muscle-induced pulmonary embolism (PE).
"
2.
Sinus Tachycardia
09/01/1986 - "
When ZSY-27 was intravenously administered to the donor dog, a dose-dependent depressor effect with slight sinus tachycardia was induced in the donor dog.
"
3.
Pulmonary Embolism
02/01/1989 - "
Selective pulmonary vasodilatory effect of ZSY-27 in dogs with pulmonary hypertension due to pulmonary embolism.
"
02/01/1989 - "
The pulmonary vasodilator effect of ZSY-27, a newly synthesized phosphodiesterase inhibitor, was studied in dogs with pulmonary hypertension resulting from autologous muscle-induced pulmonary embolism (PE).
"
Related Drugs and Biologics
1.
Vasodilator Agents (Vasodilators)
2.
Phosphodiesterase Inhibitors